QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
Free Trial
ASX:OSX

Osteopore (OSX) Stock Price, News & Analysis

→ Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad)
Free OSX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Osteopore

Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. The company has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

OSX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive OSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osteopore and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
ASX:OSX
CUSIP
N/A
CIK
N/A
Web
www.osteopore.com
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,870,000.00
Net Margins
-219.71%
Pretax Margin
N/A
Return on Equity
-392.20%
Return on Assets
-79.20%

Debt

Debt-to-Equity Ratio
275.87
Current Ratio
0.82
Quick Ratio
6.05

Sales & Book Value

Annual Sales
$2.22 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.04 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,330,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.49
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Kei Wei Leong (Age 48)
    Executive Chairman
    Comp: $150k
  • Dr. Jing Lim
    CEO & CTO
  • Mr. Khoon Seng Goh
    Global Marketing Director
  • Ms. Shu Ning Voon
    Financial Controller
  • Ms. Kellie Davis
    Joint Company Secretary

Key Competitors

View All Competitors

Insiders


This page (ASX:OSX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The #1 Crypto for 2024
InvestorPlace
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press